cdn mobile

Cebu City cop latest COVID-19 death in PNP

By: Gabriel Pabico Lalu - Inquirer.net | August 04,2021 - 06:39 AM

MANILA, Philippines — The latest COVID-19 death in the Philippine National Police (PNP) is a police officer assigned in Cebu City, PNP chief Gen. Guillermo Eleazar said in a statement issued on Tuesday.

The officer was identified as a 51-year-old master sergeant who showed mild COVID-19 symptoms on July 30 and got an RT-PCR test the next day that showed a positive result.

The officer was declared dead by his attending physician at 3 p.m. on Aug. 1

“We are all commiserating with the family of the police officer. We also found out that he had already received his first dose of the COVID-19 vaccine,” Eleazar said in Filipino.

“This is a reminder for our colleagues in the PNP that even they have been vaccinated extreme caution would still be necessary. Wear a facemask/faceshield, wash your hands, and most of all, clean your surroundings,” he added.

As of Tuesday, the PNP registered 30,745 confirmed COVID-19 cases within its ranks, of which 1,277 are active cases. Of these cases, 110 were cases reported on Tuesday.

A total of 29,383 have so far recovered from the disease while 85 have died.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Read Next

Disclaimer: The comments uploaded on this site do not necessarily represent or reflect the views of management and owner of Cebudailynews. We reserve the right to exclude comments that we deem to be inconsistent with our editorial standards.

TAGS: COVID-19, PNP
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.